The current FBRX market cap is 26.84M. The company's latest EPS is USD -0.8663 and P/E is -1.45.
Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.51M | -3.02M | -3.42M | -4.94M | -6.86M |
Net Income | -2.57M | -3.04M | -3.4M | -4.88M | -6.75M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 36k | 0 | 0 | 0 | 0 |
Operating Income | -61.51M | -46.28M | -21.49M | -13.9M | -32.49M |
Net Income | -63.52M | -46.49M | -21.71M | -13.88M | -31.48M |
Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 41.3M | 39.72M | 45.13M | 42M | 36.71M |
Total Liabilities | 1.26M | 1.51M | 2.29M | 3.18M | 3.76M |
Total Equity | 40.05M | 38.21M | 42.84M | 38.82M | 32.95M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 28.16M | 61.24M | 43.31M | 42M | 38.98M |
Total Liabilities | 17.31M | 2.26M | 1.76M | 3.18M | 3.67M |
Total Equity | 10.85M | 58.98M | 41.55M | 38.82M | 35.31M |
Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -1.98M | -3.35M | -5.29M | -8.19M | -5.2M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | -34k | -144k | 7.3M | 7.24M | 6k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -59.24M | -18.42M | -16.68M | -8.19M | -28.71M |
Investing | 42.32M | 3.58M | N/A | N/A | 47k |
Financing | -14.91M | 66.67M | -44k | 7.24M | 24.68M |
Market Cap | 26.84M |
Price to Earnings Ratio | -1.45 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.23 |
Price to Book Ratio | 1.3 |
Dividend Yield | - |
Shares Outstanding | 36.34M |
Average Volume (1 week) | 31.4k |
Average Volume (1 Month) | 28.85k |
52 Week Change | -30.32% |
52 Week High | 1.1497 |
52 Week Low | 0.38 |
Spread (Intraday) | 0.08 (10.26%) |
Company Name | Forte Biosciences Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.fortebiorx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.